MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-18-0020542
Sarala Pharma Private Limited
Sarala Pharma Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.2 Cr
▲ 2% YoY
Net profit · FY 2024
₹4,427
Net margin 0%
EBITDA · FY 2024
₹50,577
EBITDA margin 0.2%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹75 Lakh
Satisfied ₹40 Lakh
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Sarala Pharma Private Limited
Data last updated:
Sarala Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74900WB2015PTC207151. Its GSTIN is 19AAWCS0062M1ZO (West Bengal).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Malay Sarkar and Sonali Sarkar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1049 Kusumba Narendrapur, Kolkata, West Bengal, India – 700103.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.2 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹4,427 (net margin 0%) and EBITDA of ₹50,577 (EBITDA margin 0.2%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹75 Lakh and satisfied charges of ₹40 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
Sarala Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-18-0020542). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74900WB2015PTC207151
Registration Number 207151
Incorporation Date 20 July 2015
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-18-0020542
Key People
Malay Sarkar Director Sonali Sarkar Director Recognitions & Rankings of Sarala Pharma
Contact details
Sarala Pharma Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1049 Kusumba Narendrapur, Kolkata, West Bengal, India – 700103
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sarala Pharma Private Limited, buy the company report.
Comprehensive company report
Sarala Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sarala Pharma is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Sarala Pharma Private Limited, buy the company report.
Financials of Sarala Pharma Private Limited
FY 2024 filings availableSarala Pharma Private Limited reported revenue of ₹2.2 Cr (up 2% YoY) for FY 2024.
Revenue · FY 2024
₹2.2 Cr ▲ 2%
Net profit · FY 2024
₹4,427 margin 0%
EBITDA · FY 2024
₹50,577 margin 0.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▼ 22%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▼ 77%
3 years · compounded
▼ 37%
5 years · compounded
▼ 20%
Revenue rose 2% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA fell 77% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹50,577 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,427 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sarala Pharma Private Limited, buy the company report.
Board of directors of Sarala Pharma Private Limited
Sarala Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Malay Sarkar | Director | 20 Jul 2015 | 11 Years 3 Months | Current |
| Sonali Sarkar | Director | 20 Jul 2015 | 11 Years 3 Months | Current |
Auditor
Sarala Pharma Private Limited is audited by Sourabh Majumdar & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sourabh Majumdar & Associates | FY 2023 | 324201E |
Shareholding
The shareholding of Sarala Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sarala Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹75 Lakh
Satisfied charges
₹40 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Aug 2024 | 100973210 | Uco Bank | ₹75 Lakh | Open | |
| 12 Sep 2017 | 100152034 | Syndicate Bank | ₹40 Lakh | Satisfied |
To see the full charge records of Sarala Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Sarala Pharma Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Total cases
2
Filed against the company
2
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed against the company by Piramal Enterprises Limited, Authorized Sukriti Bhargava | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Piramal Enterprises Limited | Pending |
To see the full case history of Sarala Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sarala Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sarala Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAWCS0062M1ZO | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sarala Pharma Private Limited, buy the company report.
Recent activity
Sarala Pharma Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Amin Mohd Molla ceased to be Director on 18 Jan 2021.
AGM
Sarala Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Uco Bank amounted to Rs. 75.00 Lakh with Charge ID 100973210 was registered on 02 Aug 2024.
Filing
Sarala Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata.
Charges
A charge registered on 12 Sep 2017 via Charge ID 100152034 with Syndicate Bank was fully satisfied on 30 Oct 2021.
Ceased
Amin Mohd Molla ceased to be Director.
Ceased
Mohd Molla Nasim ceased to be Director.
Ceased
Rafi Mahamad Molla ceased to be Director.
Charges
A charge with Syndicate Bank amounted to Rs. 40.00 Lakh with Charge ID 100152034 was registered on 12 Sep 2017.
Appointed
Malay Sarkar was appointed as Director.
Appointed
Sonali Sarkar was appointed as Director.
Incorporation
20 Jul 2015
Sarala Pharma Private Limited was registered on 20 Jul 2015 with Roc Kolkata & aged 11 years 3 months as per MCA records.
Frequently asked questions
Sarala Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 July 2015 (11+ years old) and is registered under CIN U74900WB2015PTC207151.
Sarala Pharma has 2 current directors:
- Malay Sarkar - Director
- Sonali Sarkar - Director
The latest financial statements of Sarala Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sarala Pharma is 19AAWCS0062M1ZO, registered in West Bengal.
The CIN (Corporate Identification Number) of Sarala Pharma is U74900WB2015PTC207151. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sarala Pharma has 2 court cases on record: 2 filed against it. 2 are pending.
Sarala Pharma was incorporated on 20 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kolkata.
Amin Mohd Molla ceased to be Director on 18 Jan 2021. Mohd Molla Nasim ceased to be Director on 18 Jan 2021. Rafi Mahamad Molla ceased to be Director on 18 Jan 2021. Sarala Pharma has 5 board changes on record in total.
Yes, Sarala Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-18-0020542).
The registered office of Sarala Pharma is at 1049 Kusumba Narendrapur, Kolkata, West Bengal, India – 700103.